Is ONCT or JEPQ a better dividend investment in 2026?

ONCT currently yields 379.79% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: ONCT offers higher current income.

What is the dividend yield difference between ONCT and JEPQ?

ONCT has a forward dividend yield of 379.79% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 368.69 percentage points.

Home › Compare › ONCT vs JEPQ

ONCT vs JEPQ: Dividend Comparison 2026

ONCT yields 379.79% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ONCT wins by $7846.54M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ONCT

● Live price

379.79%

Share price

$0.53

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7846.59M

Annual income

$5,169,197,450.71

Full ONCT calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — ONCT vs JEPQ

📍 ONCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ONCT	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ONCT + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ONCT pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ONCT

Annual income on $10K today (after 15% tax)

$32,282.57/yr

After 10yr DRIP, annual income (after tax)

$4,393,817,833.10/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, ONCT beats the other by $4,393,816,003.40/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ONCT + JEPQ for your $10,000?

ONCT: 50%JEPQ: 50%

100% JEPQ50/50100% ONCT

Portfolio after 10yr

$3923.32M

Annual income

$2,584,599,801.64/yr

Blended yield

65.88%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ONCT right now

ONCT

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$28.00

+5217.1% upside vs current

Range: $28.00 — $28.00

Altman Z

-28.6

Piotroski

2/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ONCT buys

JEPQ buys

No recent congressional trades found for ONCT or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricONCTJEPQ

Forward yield	379.79% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7846.59M ✓	$44.8K
Annual income after 10y	$5,169,197,450.71 ✓	$2,152.59
Total dividends collected	$7596.65M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ONCT vs JEPQ ($10,000, DRIP)

Year	ONCT Portfolio	ONCT Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$48,679	$37,979.49	$11,930	$1,110.39	+$36.7K → ONCT
2	$224,874	$172,787.13	$14,133	$1,224.34	+$210.7K → ONCT
3	$986,585	$745,969.70	$16,632	$1,340.46	+$970.0K → ONCT
4	$4,114,314	$3,058,668.09	$19,454	$1,457.97	+$4.09M → ONCT
5	$16,323,283	$11,920,966.77	$22,626	$1,576.08	+$16.30M → ONCT
6	$61,667,489	$44,201,576.55	$26,175	$1,694.09	+$61.64M → ONCT
7	$222,048,216	$156,064,002.73	$30,133	$1,811.32	+$222.02M → ONCT
8	$762,773,776	$525,182,185.09	$34,531	$1,927.17	+$762.74M → ONCT
9	$2,502,234,339	$1,686,066,398.09	$39,403	$2,041.08	+$2502.19M → ONCT
10	$7,846,588,193	$5,169,197,450.71	$44,787	$2,152.59	+$7846.54M → ONCT

ONCT vs JEPQ: Complete Analysis 2026

ONCT — Stock

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.

Full ONCT Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this ONCT vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ONCT vs SCHD ONCT vs JEPI ONCT vs O ONCT vs KO ONCT vs MAIN ONCT vs XYLD ONCT vs QYLD ONCT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.